Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
Dr reddys laboratories ltd
1. gtÇtç eÉç XåvÄâá|äx
COMPANY FINALYTICS
Dr Reddys Laboratories Ltd
Exclusive Financial Analysis of Indian Companies
Prepared and Edited By‐
Tanay Roy, CFA
Peu Karak, MBA
Disclaimer
The information, opinions, estimates and forecasts contained in this document have been arrived at or obtained from public sources believed
to be reliable and in good faith which has not been independently verified and no warranty, express or implied, is made as to their accuracy,
completeness or correctness.
For more information about this sample and our other services, please write to tanay.roy2008@gmail.com
Monday, September 19, 2011
2. Description Page
Summary 3
Latest Result 3
Valuation Matrix 3
ROE Analysis 3
Income Statement 4
Balance Sheet 5
Cashflow Statement 6
Quarterly Result 6
Growth Analysis 7
Comparative Analysis 8
Income Statement 8
Balance Sheet 8
Index Analysis 9
Income Statement 9
Balance Sheet 9
Ratio Analysis 10
Annual 10
Quarterly 11
TTM Analysis 11
Technical Analysis 12
CONTENT
About Tanay & Peu
Our passion lies in the field of financial research & Investment management and we intend to apply
our knowledge gained over a period of years through intense study and keen observation of the
nuances of financial markets and instruments to real life scenarios. We possess expert knowledge of
financial products and markets as evidenced by top notch qualifications earned by us , all in the first
attempt and keep ourselves abreast with the latest happenings and innovations taking place in
financial landscape.
1. Expertise in Portfolio Management, Product optimization, Product performance Analysis, Financial
Reporting/ Planning, Cash Flow Analysis, Ratio Analysis, Budgeting, Forecasting, Mergers &
Acquisition and knowledge of GAAP/ IFRS
2. Possess Strong Financial Modeling skills including DCF, LBO and other techniques. Possess ability to
research all asset classes in a broad range of industries and geographies.
3. Strong equity research, finance, accounting and advisory and assurance experience
4. Expertise in Technical analysis, fundamental analysis, developing trading systems.
5. Conduct in‐depth financial analysis of company financials.
6. Write analytical or trend based reports on companies, sectors or markets.
7. Expert level application in Bloomberg, Thomson Banker, Factset, Datastream, StockVal, Merger
markets, Reuters Knowledge, Haver Analytics, Factiva, PackHedge,
8. Building Excel/VBA based customized tools to perform detailed analysis.
Contact Us: tanay.roy2008@gmail.com
Page 2
3. Summary
At a Glance
Latest Results Industry Pharmaceuticals
Yearly Quarterly TTM Business Group Reddy Group
March ' 11 Growth June ' 11 Growth June ' 11 Growth Face Value 5
Latest Results
Number of Equity shares 1692.53
EBDITA 1335.00 5.13 667.30 26.01 1691.66 24.31
Reported Net
Profit 893.00 5.56 454.05 173.74 1102.89 23.46 Price 1522.3
Adjusted PAT 891.90 16.12 454.05 173.74 NA NA
Market Cap(Rs. In Cr) 25561.24
Valuation Matrix Share Holding
Annual TTM Ratio General
Public Promote
Particulars March ' 11 March ' 11
8% r
26%
Reported P/E 28.84 28.88
Other
Price/Sales Per Share 4.97 4.86
27%
Price/ Book Value 4.28 NA
Dividend Yield FII MF
0.01 NA
25% 7%
Earning Yield 0.03 0.03
BFI
Market Cap(Rs. In Cr) 25561.24 8%
ROE Analysis
ROE
Particulars March ' 07 March ' 08 March ' 09 March ' 10 March ' 11 30%
25%
Reported PAT / PBT 0.84 0.87 0.73 0.84 0.85 20%
Adjusted PAT / PBT 0.86 0.80 0.78 0.76 0.85 15%
10%
PBT / PBIT 0.96 0.97 0.97 0.98 0.99 5%
PBIT / Sales 0.38 0.17 0.20 0.23 0.20 0%
Sales / Total Assets 0.63 0.50 0.54 0.53 0.56 March ' March ' March ' March ' March '
07 08 09 10 11
Total Assets / Net Worth 1.36 1.38 1.40 1.41 1.54
Reported ROE 26% 10% 11% 14% 15% Reported ROE Adjusted ROE
Adjusted ROE 27% 9% 11% 13% 15%
ROE Factors
1.80 30%
1.60
25%
1.40
1.20 20%
1.00
15%
0.80
0.60 10%
0.40
5%
0.20
0.00 0%
March ' 07 March ' 08 March ' 09 March ' 10 March ' 11
Reported ROE Reported PAT / PBT PBT / PBIT
PBIT / Sales Sales / Total Assets Total Assets / Net Worth
Page 3
4. Income Statement
Particulars (Rs. In Cr) March ' 07 March ' 08 March ' 09 March ' 10 March ' 11
Net Sales 3783.26 3343.89 3999.50 4395.60 5188.50
Operating Expenses
Material Consumed 1121.59 1253.46 1469.90 1482.10 1670.50
Manufacturing Expenses 213.46 207.46 195.90 221.40 274.10
Personnel Expenses 299.04 366.28 412.50 516.40 702.70 Operating Income
Selling Expenses 323.40 375.37 448.70 443.80 477.00
6000.00
Adminstrative Expenses 498.42 558.60 714.50 643.40 844.70
Expenses Capitalised 0.00 0.00 0.00 0.00 0.00 5000.00
Total Operating Expenses 2455.91 2761.17 3241.50 3307.10 3969.00
4000.00
Operating Profit 1327.35 582.72 758.00 1088.50 1219.50
Other Income 272.74 156.64 249.70 181.30 115.50 3000.00
EBDITA 1600.09 739.36 1007.70 1269.80 1335.00
2000.00
Depreciation 133.50 161.99 193.60 222.40 247.90
Other Write offs 18.16 20.71 19.70 19.30 26.80
1000.00
EBIT 1448.43 556.66 794.40 1028.10 1060.30
Interest 51.96 14.69 27.40 16.00 9.90 0.00
EBT 1396.47 541.97 767.00 1012.10 1050.40 March March March March March
' 07 ' 08 ' 09 ' 10 ' 11
Income Tax 188.99 108.88 168.60 238.70 158.50
Adjusted PAT 1207.48 433.09 598.40 773.40 891.90 Net Sales Operating Profit EBDITA
Non Recurring Items (38.79) 40.65 (37.50) 72.70 1.50
Other Non Cash adjustments (0.02) (0.06) (0.10) (0.10) (0.40)
Reported Net Profit 1168.67 473.68 560.80 846.00 893.00
Equity Dividend 62.97 63.06 105.30 190.00 190.40
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Dividend Tax 10.70 10.72 17.80 31.60 115.20
Retained Earnings 1095.00 399.90 437.70 624.40 587.40
Profit Levels Total Income Break‐up
1800.00
Total Operating Expenses Depreciation
1600.00 Other Write offs Interest
1400.00 Income Tax Adjusted PAT
1200.00
1000.00
800.00 17%
600.00
3%
400.00 0%
5%
200.00
0.00
March ' 07 March ' 08 March ' 09 March ' 10 March ' 11 75%
Operating Profit EBDITA EBIT
EBT Adjusted PAT
Page 4
5. Balance Sheet
Particulars (Rs. In Cr) March ' 07 March ' 08 March ' 09 March ' 10 March ' 11
SOURCES OF FUNDS
Owner's Fund
Equity Share Capital 83.96 84.09 84.20 84.40 84.60
Share Application Money 0.00 0.00 0.00 0.00 0.00
Preference Share Capital 0.00 0.00 0.00 0.00 0.00
Reserves & Surplus 4289.40 4727.72 5174.90 5830.20 5935.60
Total Owners fund 4373.36 4811.81 5259.10 5914.60 6020.20
Loan Funds
Secured Loans 1.92 3.40 2.60 0.80 0.70
Unsecured Loans 327.98 458.91 637.70 562.40 1444.10
Total Loan fund 329.90 462.31 640.30 563.20 1444.80
Capital Structure
Total 4703.26 5274.12 5899.40 6477.80 7465.00
7000.00
USES OF FUNDS
Fixed Assets 6000.00
Gross Block 1291.19 1750.21 2157.30 2425.70 3025.00
Less : Revaluation Reserve 0.00 0.00 0.00 0.00 0.00
5000.00
Less : Accumulated
Depreciation 609.15 762.80 946.50 1110.10 1334.00
Net Block 682.04 987.41 1210.80 1315.60 1691.00 4000.00
Capital Work‐in‐progress 280.61 245.71 411.20 745.40 570.40
Investments 966.99 2080.71 1865.10 2652.70 2462.00 3000.00
Net Current Assets
Current Assets, Loans & 2000.00
Advances 4028.55 3348.01 3870.40 3647.30 4563.70
Less : Current Liabilities & 1000.00
Provisions 1254.93 1387.74 1458.10 1883.20 1822.10
Total Net Current Assets 2773.62 1960.27 2412.30 1764.10 2741.60
0.00
Miscellaneous expenses not
written 0.00 0.00 0.00 0.00 0.00 March ' March ' March ' March ' March '
Total 07 08 09 10 11
4703.26 5274.10 5899.40 6477.80 7465.00
Note :
Total Owners fund Total Loan fund
Book Value of Unquoted
Investments 966.68 2080.41 1864.80 2652.40 2614.80
Market Value of Quoted
Investments 1.20 1.92 53.00 360.10 3.30
Contingent liabilities 1896.92 1892.55 1934.80 2016.10 1526.00
Number of Equity shares
outstanding (in Lacs) 1679.12 1681.73 1684.69 1688.45 1692.53
Sources of Capital Application of capital
Total Loan
fund
19%
Net Block
Total Net
23%
Current Assets
37% Capital
Work‐
in‐
Total Owners progress
fund 7%
Investments
81% 33%
Page 5
6. Cash Flow Statement
Particulars (Rs. In Cr) March ' 07 March ' 08 March ' 09 March ' 10 March ' 11
Profit Before Tax 1365.85 584.10 729.50 1084.80 1051.90
Net CashFlow‐Operating
Net Cash Flow
Activity 893.79 555.87 481.30 1253.20 246.30
Net Cash Used In Investing
Activity (397.32) (1515.93) (743.60) (1111.10) (613.00) 316.59
NetCash Used in Fin. Activity 105.60
316.59 46.15 105.60 (152.20) 61.00 893.79 46.15 61.00
1253.20
Net Inc/Dec In Cash And 555.87 481.30 246.30
Equivlnt 805.77 (913.91) (156.70) (10.10) (305.70)
(397.32)
Cash And Equivalnt Begin of (1111.10)
650.94 1451.25 541.10 378.10 371.90 (743.60) (613.00)
Year (1515.93)
Cash And Equivalnt End Of (152.20)
Year 1456.71 537.34 384.40 368.00 66.20
Net CashFlow‐Operating Activity
Net Cash Used In Investing Activity
NetCash Used in Fin. Activity
Quarterly Result
September '
Particulars (Rs. In Cr) June ' 10 10 December ' 10 March ' 11 June ' 11
Sales 1,271.26 1,296.88 1,389.76 1,346.66 1,696.96
Less: Excise 0.00 0.00 0.00 0.00 0.00
Net Sales 1,271.26 1,296.88 1,389.76 1,346.66 1,696.96
Profit Levels
Other Income 20.92 52.35 37.21 29.11 55.54
Total Income 1,292.18 1,349.23 1,426.97 1,375.77 1,752.50
Stock Adjustment (33.73) 4.68 (50.52) 0.58 (31.46)
Raw Material 438.26 419.72 487.72 465.46 478.04
Power And Fuel 0.00 0.00 0.00 0.00 0.00
Employee Expenses 153.89 189.10 169.16 188.97 203.63
Admin And Selling Expenses 130.19 108.85 126.38 111.71 139.28
Research And Devlopment Expe 94.43 0.00 0.00 161.53 119.11
Expenses Capitalised 0.00 0.00 0.00 0.00 0.00
Other Expeses 172.62 300.63 313.89 129.75 176.60
Total Expenses 955.66 1,022.98 1,046.63 1,058.00 1,085.20
EBDITA 336.52 326.25 380.34 317.77 667.30
Provisions Made 0.00 0.00 0.00 55.74 0.00
Depreciation 57.20 61.35 63.89 65.50 68.93
EBIT 279.32 264.90 316.45 196.53 598.37
Interest 0.46 0.13 0.54 4.25 15.24
EBT 278.86 264.77 315.91 192.28 583.13
Taxation 34.38 44.57 53.14 26.41 129.08
Net Profit / Loss 244.48 220.20 262.77 165.87 454.05
Extra Ordinary Item 0.00 0.00 0.00 0.00 0.00 EBDITA EBIT
Prior Year Adjustments 0.00 0.00 0.00 0.00 0.00
EBT Net Profit / Loss
Page 6